Alan Donze - Medical Device Executive

Alan Donze's Bio:

Alan has over 35 years of experience working in the Medical Device and Technology space, of which over 25 years have been at various Management and Senior Management positions. He currently serves as the Chief Executive Officer for Bioretec. Bioretec is a globally operating Finnish medical device company that pioneers the application of bioresorbable orthopedic implants. Prior to his current position Alan served as Chief Operating Officer for the cybersecurity firm, myNetWatchman. Previously he served as Senior Vice President of Marketing & Sales for the digital health company, Rx.Health. Prior to joining Rx.Health, he served as Chief Commercial Officer for Aerobiotix, combatting airborne viruses and contaminants in the operating room and other spaces. Prior to that, he spent several years serving as VP, Americas for Lima Corporate as well as VP GM of Lima USA, which specializes in advanced Trabecular Titanium Shoulders, Hips and Knees. Previously he spent six years as an Executive Team Member with Smith & Nephew (and their spin off Bioventus). Preceding that he spent two years with Isotis Orthobiologics building up their sales to be acquired by Integra LifeSciences and 13 years with Stryker in increasing management roles within several divisions (Endoscopy, Communications, ProCare) starting as a Sale Rep and working up through the ranks to Vice President General Manager. Alan has an extensive financial background with experience in Corporate and Investment Banking, facilitating Leveraged Buyout and IPO financing, along with traditional corporate banking services.

Alan Donze's Experience:

  • Chief Executive Officer at Bioretec, Ltd

    Present | Tampere, Finland

  • Chief Operation Officer at Mynetwatchman

    2021 - 2023

    MyNetWatchman is the leading cyber intelligence and investigations firm specializing in the analysis of network data for fraud management. We analyze and investigate network data in real-time for our customers, and provide them with actionable intelligence that is incorporated into their fraud management and recovery programs.

  • SVP Sales & Marketing at Rx.Health (acquired by Commure)

    October 2020 - 2021 | New York, US

    Rx.Health is defining the delivery of digital medicine by bringing the first enterprise-wide curation, prescription, and engagement platform to hospitals, pharma, and payers in an affordable and scalable way. Rx.Health partners with life sciences, national societies, health systems, and payers.

  • Chief Commercial Officer at Aerobiotix

    2019 - 2020 | Dayton, OH

    Aerobiotix, Inc. is an innovative company driving leadership in advanced air quality products for the healthcare market to kill airborne microbes in the operating room and various other settings. Aerobiotix, Inc. designs, develops, manufactures and markets the Illuvia® HUAIRS, which is currently the only FDA approved technology tested and proven to remove airborne SARS-CoV-2. Responsible for all Sales and Commercial activities Worldwide.

  • Chief Commercial Officer at Rep-Lite

    2017 - 2019

    Lower Cost of Sales, Higher Quality of Service Staffed with the healthcare industry’s most skilled and experienced healthcare equipment technicians and professionals, the goal of Rep-Lite’s medical manufacturer support is to streamline the vendor relations process and let you get back to the business of healthcare as it was intended.

  • Vice President, General Manager - Americas at Lima Corporate (acquired by Enovis)

    2014 - 2017 | Dallas, TX

    Lima Corporate is a global medical device company that designs, develops, manufactures and markets joint replacement and repair solutions that include large joint implants for hip and knee and systems for the restoration of the extremities focusing on disorders of the shoulder and traumatic injuries. Built Quality, Sales, Marketing, Operations, Distribution, Customer Service, Professional Affairs, Medical Education and Finance departments from scratch. Directly participated in the successful equity sale of Lima to private equity in 2016.

  • Vice President Sales/Commercial Operations - Americas at Bioventus (Formerly Smith & Nephew Biologics)

    2012 - 2013 | Raleigh/Durham, NC

    Continued operating as VP Sales/Commercial Operations after Bioventus was formed following a joint venture with Smith & Nephew and Essex woodlands.

  • Vice President Sales/Commercial Operations - Americas at Smith & Nephew Biologics, Spine and Clinical Therapies

    2007 - 2012 | Memphis, TN and Raleigh/Durham, NC

    In charge of Sales and Commercial Operations for Biologics, Spine and Clinical Therapies. Managed three distinct sales forces with total personnel managed at over 350. Grew Exogen long bone stimulation product line from number two globally to number one. Grew Joint Fluid Therapy product line from number two globally to number one (syringe volume).

  • Senior Vice President - Global Sales at Isotis Orthobiologics (acquired by Integra LifeSciences)

    2006 - 2007 | Irvine, CA

    IsoTis Orthobiologics is a leader in the development of natural human bone morphogenetic proteins and demineralized bone matrix as graft substitutes for Spine, Orthopaedic, and Trauma Surgery. Built up US and International Sales to ultimately be acquired by Integra Lifesciences in 2007.

  • VP, GM at Stryker Communications and Stryker Endoscopic Services

    1991 - 2004

    Held various positions, including: Sales Representative for Stryker Endoscopy, Regional Sales Manager for Stryker Endoscopy, Director of Strategic Marketing for Stryker Endoscopy, VP GM Stryker Endoscopic Services and VP GM Stryker Communications. Alan served as VP, GM of two divisions of Stryker Corporation with full P&L responsibility. He managed Stryker Communications as a wholly owned, fully self-sufficient subsidiary of Stryker, managing all aspects including R&D, Clinical/Regulatory, Finance, Manufacturing, Sales & Marketing, Operations, Business Development, Information Technology & Human Resources.

  • Vice President, Senior Commercial Lender at Hibernia Corporation

    1989 - 1991 | New Orleans, LA

    Aggressively built commercial loan, cash management and depository market share in Fortune 500 companies throughout the Western half of the United States.

Alan Donze's Education:

  • Louisiana State University

    BS Finance
    Concentration: Corporate Finance

Alan Donze's Interests & Activities:

medical devices, orthopaedics, snowboarding, road biking, scuba diving, travel.